Becton Dickinson & Co (BDX) stock
BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3016% above fair value
$214.52+1.91 (+0.90%)
Close on Nov 11, 2026Market cap $58.43BP/E 64.8Yield 1.94%
Becton Dickinson total assets
Total assets on the balance sheet at the end of each period.
Becton Dickinson's total assets was $50.73B at Jun 30, 2026. For fiscal 2025 it was $55.33B, down 3.4% from the year before. Over ten years it grew 7.6% a year on average. The highest annual figure on record is $57.29B in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $55.33B | -3.4% |
| FY2024 | Sep 30, 2024 | $57.29B | +8.5% |
| FY2023 | Sep 30, 2023 | $52.78B | -0.3% |
| FY2022 | Sep 30, 2022 | $52.93B | -1.7% |
| FY2021 | Sep 30, 2021 | $53.87B | -0.3% |
| FY2020 | Sep 30, 2020 | $54.01B | +4.3% |
| FY2019 | Sep 30, 2019 | $51.77B | -4.0% |
| FY2018 | Sep 30, 2018 | $53.90B | +42.9% |
| FY2017 | Sep 30, 2017 | $37.73B | +47.5% |
| FY2016 | Sep 30, 2016 | $25.59B | -3.4% |
| FY2015 | Sep 30, 2015 | $26.48B | +113.8% |
| FY2014 | Sep 30, 2014 | $12.38B | +1.9% |
| FY2013 | Sep 30, 2013 | $12.15B | +6.9% |
| FY2012 | Sep 30, 2012 | $11.36B | +8.9% |
| FY2011 | Sep 30, 2011 | $10.43B | +8.1% |
| FY2010 | Sep 30, 2010 | $9.65B | +3.7% |
| FY2009 | Sep 30, 2009 | $9.30B | +17.6% |
| FY2008 | Sep 30, 2008 | $7.91B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $50.73B | -7.6% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $50.83B | -6.7% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $54.84B | +0.3% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $55.33B | -3.4% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $54.90B | -1.2% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $54.47B | +0.6% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $54.67B | +4.6% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $57.29B | +8.5% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $55.58B | +4.8% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $54.16B | -0.4% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $52.27B | -1.6% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $52.78B | -0.3% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $53.02B | -0.3% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $54.39B | -0.7% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $53.13B | -0.4% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $52.93B | -1.7% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $53.20B | -2.1% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $54.79B | -0.2% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $53.36B | -2.5% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $53.87B | -0.3% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $54.33B | +0.7% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $54.92B | +2.6% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $54.75B | +5.4% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $54.01B | +4.3% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $53.96B | +3.3% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $53.52B | +1.7% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $51.95B | -1.9% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $51.77B | -4.0% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $52.23B | -3.2% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $52.60B | -3.6% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $52.93B | -4.4% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $53.90B | +42.9% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $53.98B | +45.2% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $54.57B | +126.2% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $55.36B | +127.7% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $37.73B | +47.5% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $37.17B | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $24.12B | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $24.32B | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $25.59B | – |
See a number that looks wrong?